Diabetes Mellitus, Type 2 Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
V
Withdrawn
  • Diabetes Mellitus, Type 2
  • Chronic Kidney Diseases
  • Empagliflozin 10 MG
  • +2 more
  • (no location specified)
2021-10-05
Oct 5, 2021
B
Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Medication Adherence
  • Reinforcement Learning
  • Boston, Massachusetts
    Brigham and Women's Hospital
2021-09-29
Sep 29, 2021
H
Recruiting
  • Diabetes Mellitus, Type 2
  • Cardiac Surgery
  • Dapagliflozin 10 MG
  • Placebos
  • Beijing, Beijing, China
    Beijing Anzhen Hospital, Capital Mediacal University
2021-10-06
Oct 6, 2021
A
Suspended
  • Diabetes Mellitus, Type 2
  • +2 more
  • Bronx, New York
    Albert Einstein College of Medicine
2021-09-30
Sep 30, 2021
M
Active, not recruiting
  • Chronic Obstructive Pulmonary Disease
  • +3 more
  • Assessment of Burden of Chronic Conditions (ABCC)-tool
  • Maastricht, Limburg, Netherlands
    Maastricht University
2021-10-06
Oct 6, 2021
N
Completed
  • Diabetes Mellitus, Type 2
  • insulin icodec
  • Insulin glargine
  • Graz, Austria
    Novo Nordisk Investigational Site
2021-10-06
Oct 6, 2021
U
Recruiting
  • Diabetes Mellitus, Type 2
  • HIV Infections
  • MTM + ILI
  • Standard MTM
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill
2021-10-06
Oct 6, 2021
U
Active, not recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • Lifestyle
  • Aurora, Colorado
    University of Colorado
2021-09-29
Sep 29, 2021
Z
Recruiting
  • Diabetic Angiopathies
  • Diabetes Mellitus, Type 2
  • liquid chromatography-mass spectrometry
  • Chongqing, Chongqing, China
    The third hospital affiliated to the Third Military Medical Univ
2021-09-25
Sep 25, 2021
M
Not yet recruiting
  • Osteoarthritis, Knee
  • +3 more
  • Continuous glycemia measuring device (Dexcom) implantation into the subcutaneous tissue
  • (no location specified)
2021-10-05
Oct 5, 2021
S
Enrolling by invitation
  • Diabetes Mellitus, Type 2
  • +2 more
  • Peer Support Intervention via Instant Messaging Service Tool (IMS-Tool)
  • antidiabetic therapy according to the current guidelines
  • St. Pölten, Lower Austria, Austria
    Sankt Pölten University of Applied Sciences
2021-09-28
Sep 28, 2021
B
Recruiting
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +91 more
2021-10-05
Oct 5, 2021
U
Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Food support
  • Case-management
  • Martinez, California
    Contra Costa Health Services
2021-09-29
Sep 29, 2021
U
Recruiting
  • Cancer, Breast
  • +6 more
  • FHAMe Intervention
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
2021-09-27
Sep 27, 2021
U
Completed
  • Diabetes Mellitus, Type 2
  • GEM + CGM
  • Charlottesville, Virginia
    Dept. of Psychiatry and Neurobehavioral Sciences, University of
2021-10-04
Oct 4, 2021
B
Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Aichi, Nagoya, Japan
  • +17 more
2021-10-04
Oct 4, 2021
N
Enrolling by invitation
  • Diabetes Mellitus, Type 2
  • Aichi, Japan
  • +413 more
2021-10-04
Oct 4, 2021
D
Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Pre-diabetes
  • G6
  • Lemon Grove, California
  • +4 more
2021-10-04
Oct 4, 2021
B
Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Aarhus, Denmark
    Department of Clinical Epidemiology - Aarhus Unversiteteshospita
2021-10-04
Oct 4, 2021
B
Active, not recruiting
  • Diabetes Mellitus, Type 2
  • BI 456906
  • +2 more
  • Huntington Park, California
  • +79 more
2021-10-04
Oct 4, 2021
B
Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Helsinki, Finland
  • +2 more
2021-10-04
Oct 4, 2021
U
Completed
  • Diabetes Mellitus, Type 2
  • Weight reduction training
  • +3 more
  • Charlottesville, Virginia
    Dept. of Psychiatry and Neurobehavioral Sciences, University of
2021-10-04
Oct 4, 2021
B
Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Boston, Massachusetts
    Bringham Women Hospital
2021-10-04
Oct 4, 2021